Herskowitz Neil Insider Trading Activity

Average Profitability
168.29%
Insider Buys Quantity
27
Insider Buys Sum
$440,364.74
Insider Sells Quantity
1
Insider Sells Sum
$46.00

Insider Activity of Herskowitz Neil

According to the SEC Form 4 filings, Herskowitz Neil, being in a position of

  1. director at Mustang Bio, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 247 shares for $238,
    over all time since 2018-11-23, has bought 1000 shares for $3,960, and sold 247 shares for $238.

Biography of Herskowitz Neil

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2381100

Comparison of Insiders on Amount of Buys and Sells

2025-12-30SaleMustang Bio, Inc.
MBIO
director
247
0.0034%
$0.96$238-26.31%
2018-11-23PurchaseMustang Bio, Inc.
MBIO
director
1,000
0.0002%
$3.96$3,960-17.11%
2012-12-06PurchaseTG Therapeutics, Inc.
TGTX
director
1,000
0.0049%
$2.00$2,000+168.29%
2007-03-30PurchaseTG Therapeutics, Inc.
TGTX
director
55,555
0.0005%
$0.90$50,000
2006-07-18PurchaseTG Therapeutics, Inc.
TGTX
director
5,000
<0.0001%
$0.61$3,050
2006-07-13PurchaseTG Therapeutics, Inc.
TGTX
director
5,000
<0.0001%
$0.68$3,400
2006-07-11PurchaseTG Therapeutics, Inc.
TGTX
director
9,000
<0.0001%
$0.71$6,390
2006-07-10PurchaseTG Therapeutics, Inc.
TGTX
director
1,000
<0.0001%
$0.73$730
2006-01-10PurchaseTG Therapeutics, Inc.
TGTX
director
28,400
0.0004%
$1.30$36,920
2005-04-27PurchaseTG Therapeutics, Inc.
TGTX
director
10,000
0.0001%
$1.21$12,100
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.